Chinese Clinical Oncology : Impact Factor & More
eISSN: 2304-3873pISSN: 2304-3865
Share this on:
Key Metrics
CiteScore 
4.2
SJR
Q3Oncology
SNIP
1.03
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Chinese Clinical Oncology
Chinese Clinical Oncology Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Chinese Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chinese Clinical Oncology
Development and validation of a diagnostic model based on artificial intelligence for diagnosing pancreatic cancer.
- 1 Feb 2026
- Chinese clinical oncology
The evolution of bispecific antibodies in multiple myeloma.
- 1 Feb 2026
- Chinese clinical oncology
Preventing unplanned "whoops" sarcoma surgery: from technical pearls to early referral and network-level quality metrics.
- 1 Feb 2026
- Chinese clinical oncology
The present and the future of urological management of prostate cancer.
- 1 Feb 2026
- Chinese clinical oncology
Epidemiology, biomarkers, and therapeutic approach in early-stage biliary tract cancers.
- 1 Feb 2026
- Chinese clinical oncology
Cadonilimab plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a step forward for bispecific immunotherapy?
- 1 Feb 2026
- Chinese clinical oncology
Development and validation of a diagnostic model based on artificial intelligence for diagnosing pancreatic cancer.
- 1 Feb 2026
- Chinese clinical oncology
The evolution of bispecific antibodies in multiple myeloma.
- 1 Feb 2026
- Chinese clinical oncology
Preventing unplanned "whoops" sarcoma surgery: from technical pearls to early referral and network-level quality metrics.
- 1 Feb 2026
- Chinese clinical oncology
The present and the future of urological management of prostate cancer.
- 1 Feb 2026
- Chinese clinical oncology
Epidemiology, biomarkers, and therapeutic approach in early-stage biliary tract cancers.
- 1 Feb 2026
- Chinese clinical oncology
Cadonilimab plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a step forward for bispecific immunotherapy?
- 1 Feb 2026
- Chinese clinical oncology
FAQs on Chinese Clinical Oncology
How long has Chinese Clinical Oncology been actively publishing? 
What is the publishing frequency of Chinese Clinical Oncology?
How many articles did Chinese Clinical Oncology publish last year?
What is the eISSN & pISSN for Chinese Clinical Oncology?
What is Citescore for Chinese Clinical Oncology?
What is SNIP score for Chinese Clinical Oncology?
What is the SJR for Chinese Clinical Oncology?
Who is the publisher of Chinese Clinical Oncology?
